The PhD and MS in PSC and PhD in PHSR programs have changed leadership.

Faculty and students visited APhA headquarters and met with legislators in Washington, DC.

Michel is an internationally recognized researcher and has been involved in all of the School’s educational aspects.

Mary Lynn McPherson is executive director of the Graduate Studies in Palliative Care program.

This initiative represents the intersection of community partners, pharmacists, independent pharmacies, academic centers meeting the needs of older adults across the State of Maryland.

Since June, Michel has served as interim dean and was previously chair of the Department of Pharmaceutical Sciences and associate dean for graduate programs.

Shapiro and UMSOM’s Jeffrey Hasday, MD, honored for discovery of a novel class of drugs that selectively inhibits an enzyme’s role in promoting disease-causing inflammation and has been licensed to GEn1E Lifesciences.

Paul Solinsky, a clinical staff member at the School, named Health System Pharmacist of the Year.

Former dean receives the Hartmut Derendorf Mentorship in Clinical Pharmacology Award.

When Natalie D. Eddington stepped down as dean this spring, it marked the end of a more than 15-year tenure spent in service to academic pharmacy filled with laudable accomplishments.

School of Pharmacy hosted the annual ceremony on Sept. 8.

Six major drug agencies participated in workshop.